New Therapeutic Approaches to Combat Arterial Thrombosis
Figure 5
Structures of small molecule antagonists for novel platelet targets
Structures are shown for (A) terutroban, an antagonist of the thromboxane A2 receptor; (B) vorapaxar, a PAR-1 antagonist; and (C) sarpogrelate, an antagonist of the serotonin 5-HT2A receptor.
